An expanded subtraction up to $48,000 for retired couples is among the changes to Wisconsin's income taxes this year.
"Receiving FDA clearance for expanded pediatric use marks a significant milestone for iotaMotion and for families navigating cochlear implant decisions," said Mike Lobinsky, CEO of iotaMotion. "By ...
Researchers from University of California San Diego report that an expanded, school-based tobacco prevention program in California was associated with significantly lower rates of smoking and vaping ...
XRP ETFs hold $1.3B in assets. Solana ETFs have attracted over $765M in inflows. Covered call strategies cap upside gains but create accumulation pressure that supports prices and reduces volatility.
Mike Newton is on his way to early retirement, thanks to his 26-unit real estate portfolio. Newton has financed properties with traditional 30-year mortgages and seller financing. He's recently been ...
Concerns over competitors using AI pricing tools to fix prices have dominated antitrust discussions in the U.S. and EU. Recent cases show how algorithmic pricing might enable unlawful coordination.
This past summer, a fire at an electrical substation forced data centers in Loudoun County to rely on backup diesel generators as their power source. Grid failures like this happen often, but this ...
With Android QPR2, which started rolling out a few days ago in early December, Google is bringing a slew of cool new features to Android — specifically its Pixel phones. One of these is a feature I’m ...
A judge dismissed indictments against two of the president’s foes, but a new Pentagon investigation of a prominent Democrat shows how he is using a whole-of-government approach to punish those who ...
Work mandates are back for low-income New Yorkers who get federal food aid for the first time in more than five years after being put on hold since the outset of the COVID-19 pandemic. New York had ...
To better understand which social media platforms Americans use, Pew Research Center surveyed 5,022 U.S. adults from Feb. 5 to June 18, 2025. SSRS conducted this National Public Opinion Reference ...
Regeneron Pharmaceuticals has won expanded European approval of its blockbuster cancer drug Libtayo for certain patients with skin cancer. Regeneron on Wednesday said the European Commission's nod ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results